| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 100.28 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The NASYTHOR project, aimes to study the potential of novel natural and synthetic compounds as anti-cancer drugs on hormone-resistant tumors. One of the objectives is the evaluation of the in vivo efficacy of the anticancer activity of the compounds using Danio rerio, zebrafish embryo as a model. In this work we describe the general methodology, advantages and disadvantages. Among a large range of advantages in the use of zebrafish in cancer research, the high level of genetic and physiologic homology with humans, including brain, digestive tract, musculature and vasculature can be highlighted. Also, the immature immune system of the embryos favors xenotransplantation of human cancer cells, and makes these animals a promising experimental model to tumorigenesis, angiogenesis, invasion and metastasis. The ionic liquid cetylpyridinium ampicillin [C16Pyr] [Amp] induces cytotoxicity in hormone-resistant breast and prostate cancer cell lines. To study the possible use of [C16Pyr] [Amp] as an anticancer, the toxicity towards zebrafish embryos should be evaluated first by an acute toxic assay that should be carried out following the OECD 236 Guideline.
Description
Keywords
Ionic liquids Hormone resistant tumors Zebrafish model
Citation
Barros, Piedade, Martins, R., Cruz, A., & Silva, R. (2019, abril). Evaluating the effect of the Ionic liquid [C16Pyr] [Amp] in hormone-resistant tumors using an in vivo zebrafish assay [Comunicação oral]. Workshop on R&D projects: proceedings, Porto.